These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30347032)

  • 1. Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
    Stolmeier DA; Stratman HB; McIntee TJ; Stratman EJ
    JAMA Dermatol; 2018 Dec; 154(12):1409-1416. PubMed ID: 30347032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory monitoring during antifungal treatment of paediatric tinea capitis.
    Aleohin N; Bar J; Bar-Ilan E; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2021 Feb; 64(2):157-161. PubMed ID: 33064847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
    Bar J; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
    Davis R; Balfour JA
    Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis.
    Wang Y; Geizhals S; Lipner SR
    J Am Acad Dermatol; 2021 Feb; 84(2):497-499. PubMed ID: 32387655
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
    Wingfield AB; Fernandez-Obregon AC; Wignall FS; Greer DL
    Br J Dermatol; 2004 Jan; 150(1):119-26. PubMed ID: 14746625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Griseofulvin and/or Terbinafine Induced Toxic Epidermal Necrolysis in an Adult Female Patient - A Case Report.
    Jadeja D; Jaiswal CS; Panchasra A; Tripathi CB
    Curr Drug Saf; 2016; 11(2):192-4. PubMed ID: 26695069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
    Gupta AK; Del Rosso JQ
    Int J Dermatol; 2000 Jun; 39(6):401-11. PubMed ID: 10944084
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials.
    Kuffner EK; Temple AR; Cooper KM; Baggish JS; Parenti DL
    Curr Med Res Opin; 2006 Nov; 22(11):2137-48. PubMed ID: 17076974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatments for toenail onychomycosis: a systematic review.
    Crawford F; Young P; Godfrey C; Bell-Syer SE; Hart R; Brunt E; Russell I
    Arch Dermatol; 2002 Jun; 138(6):811-6. PubMed ID: 12056964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.